Benefits
Heart Health
This is the best supported use on the page. A 2024 systematic review and meta-analysis of 20 randomized trials in 808 people found taurine lowered systolic blood pressure by about 4.0 mmHg, diastolic by about 1.4 mmHg and heart rate by about 3.6 beats per minute, and improved measures of heart pumping function, with no significant adverse effects. Those changes are real but modest. Separately, a small single-blind trial gave 500 mg three times a day for 2 weeks to 29 people already diagnosed with heart failure, and their exercise time, METS and walking distance improved more than on placebo. That describes people under medical care, not what taurine does for a healthy person. No study cited here measured arterial stiffness, arrhythmias or oxidative stress, and taurine is not a treatment for heart disease.
Exercise Performance
A 2018 meta-analysis of 10 studies using 1 to 6 grams a day found a small improvement in endurance performance (effect size 0.40) and in time to exhaustion (effect size 0.43). The same analysis found no difference between taking a single dose before exercise and taking it daily for weeks, and no sign that larger doses worked better. None of the studies cited on this page measured muscle damage, muscle soreness, recovery or oxidative damage, so those effects are not established here.
Metabolic Health
In one double-blind, placebo-controlled trial, 45 people already diagnosed with type 2 diabetes took 3,000 mg a day for 8 weeks. Fasting blood sugar, insulin, insulin resistance (HOMA-IR), total cholesterol and LDL cholesterol all improved compared with placebo. Just as important, HbA1c (the long-term blood sugar marker), triglycerides, HDL cholesterol and every body measurement including weight and waist size did not change. That is a single small trial in people with a diagnosed condition, so it does not show that taurine controls blood sugar in healthy people or that it helps with weight.
Brain Function
None of the studies cited on this page looked at the brain, memory, mood or thinking. Taurine does interact with GABA and glycine receptors in laboratory work, which is why it comes up in discussions of the nervous system, but that is background biology rather than a tested human benefit. Taurine is not a treatment for epilepsy or any other neurological condition.
Eye Health
Taurine really is present at high levels in the retina, which is why it gets mentioned in connection with vision. But none of the research cited on this page measured eyesight or eye health in any way, so there is nothing here to support taking taurine for your eyes.
Antioxidant and Anti-inflammatory Effects
This one is not backed by the evidence on this page. Not one of the four studies cited here measured antioxidant status or inflammatory markers, and none looked at cancer or kidney disease. Taurine's antioxidant behavior is described in laboratory research, but it has not been demonstrated in the human trials listed below.
Mechanism of action
Membrane Stabilization and Calcium Homeostasis
Taurine stabilizes cell membranes by interacting with phospholipids, enhancing membrane integrity and fluidity. It regulates calcium channels and pumps, maintaining intracellular calcium levels, which is critical for muscle contraction, neuronal signaling, and cardiac function. In the heart, taurine is involved in calcium-dependent processes. This is laboratory biology rather than something the human studies on this page tested; those trials measured blood pressure, heart rate, pumping function and exercise capacity, not arrhythmias.
Antioxidant Activity
Taurine neutralizes reactive oxygen species (ROS) indirectly by enhancing the activity of antioxidant enzymes like superoxide dismutase and glutathione peroxidase. It also forms taurine chloramine with hypochlorous acid, reducing oxidative damage and inflammation in tissues. This has been shown in laboratory work only. None of the human studies cited on this page measured antioxidant status, so treat this as a proposed mechanism rather than a proven effect.
Osmoregulation
As an organic osmolyte, taurine regulates cell volume by balancing intracellular and extracellular osmotic pressure. This is particularly important in cells exposed to osmotic stress, such as in the kidneys, brain, and eyes, helping maintain cellular function under varying conditions.
Neurotransmitter Modulation
Taurine acts as a neuromodulator, interacting with GABA and glycine receptors in the brain. In laboratory studies it increases inhibitory signaling. No human trial cited on this page tested mood, anxiety, seizures or any other brain outcome.
Mitochondrial Function and Energy Metabolism
Taurine supports mitochondrial health by stabilizing mitochondrial membranes and reducing ROS production. It also conjugates with bile acids, aiding fat digestion and lipid metabolism, which supports energy production and metabolic health. Improved mitochondrial efficiency in muscle is a proposed laboratory explanation for the small endurance effect seen in the exercise meta-analysis cited below. The human studies here measured performance, not mitochondrial function.
Anti-inflammatory Effects
In laboratory studies, taurine dampens pro-inflammatory signals (such as TNF-alpha and IL-1 beta) and forms taurine chloramine in immune cells. None of the human research cited on this page measured inflammatory markers, so this remains something seen in the lab rather than a demonstrated benefit, and it is not evidence that taurine protects against diabetes or cardiovascular disease.
Insulin Sensitivity and Glucose Regulation
Taurine enhances insulin signaling by reducing oxidative stress and inflammation in insulin-sensitive tissues. It may also interact with insulin receptors. The one human trial cited here that tested this was run in people already diagnosed with type 2 diabetes, where fasting blood sugar and insulin improved over 8 weeks but HbA1c did not.
Clinical trials
A 2023 Science paper by Singh and colleagues on taurine and aging in worms, mice, monkeys and humans. It is not one of the four references cited at the bottom of this page, and the parts showing a lifespan effect were in animals, not people.
Multi-species: C. elegans, mice, monkeys, humans (NHANES cohort).
Plasma taurine levels decline substantially with age in all species studied. Taurine supplementation extended lifespan in worms (~10-23%) and middle-aged female mice (~12% median lifespan). Improved healthspan markers across species. Critical caveat: human evidence is observational (NHANES correlation between low plasma taurine and age-related disease) — not interventional. The longevity field has had multiple compounds (resveratrol, NMN, rapamycin, metformin) show striking animal effects without confirmed human longevity benefit.
A 2024 pooled analysis in Nutrition & Diabetes of 25 trials of taurine in people diagnosed with metabolic syndrome. This paper is not among the four references listed at the bottom of this page, so its numbers have not been verified here.
Pooled across 25 clinical trials.
Taurine supplementation modestly reduced waist circumference, BP, fasting glucose, insulin resistance markers, and LDL cholesterol vs control. Effect sizes modest. Note: standard metabolic syndrome management primarily uses lifestyle (diet, exercise) and pharmacotherapy (metformin, statins, antihypertensives). Taurine adjunctive at most.
A 2019 double-blind trial in 24 women aged 55 to 70 given taurine or placebo, measuring oxidative stress and inflammatory markers. This study is not among the four references listed at the bottom of this page, and at 24 participants it is too small to establish an effect.
24 postmenopausal women (very small).
Modest improvements in oxidative stress markers vs placebo. Very small trial; cannot establish meaningful anti-aging efficacy.
A 2020 trial in 50 people already diagnosed with type 2 diabetes, looking at oxidative stress and inflammatory markers. This study is not among the four references listed at the bottom of this page, and it describes people under medical care for diabetes rather than healthy adults.
50 T2DM patients.
Modest reductions in oxidative stress (MDA), improvements in antioxidant enzymes (SOD, GPx), reduced inflammatory markers vs control. Standard T2DM care uses metformin/GLP-1 agonists; taurine adjunctive.
A 2016 double-blind, placebo-controlled trial in 120 adults with higher than ideal blood pressure, measuring blood pressure and vascular function. This study is not among the four references listed at the bottom of this page, and its roughly 7 mmHg systolic drop is about double the 4 mmHg average found by the verified 20-trial meta-analysis cited below.
120 prehypertensive adults.
Taurine significantly reduced clinic systolic BP (~7.2 mmHg) and 24-hour ambulatory SBP. Improved endothelial function. Reasonable adjunctive cardiovascular signal.
An 8-week trial in people diagnosed with type 2 diabetes that combined taurine with a low-carbohydrate diet. This study is not among the four references listed at the bottom of this page.
T2DM patients.
Modest synergistic improvements in glycemic control. Multi-intervention design — cannot isolate taurine-specific effects.
Pooled analysis of 20 clinical trials (searched up to January 2, 2024) examining cardiovascular effects of taurine supplementation.
808 participants pooled across 20 randomized trials, many of them in people with diagnosed heart conditions.
This is reference 2 in the list below (Nutr J 2024, 20 randomized trials, 808 people). It found taurine lowered heart rate by 3.58 beats per minute, systolic blood pressure by 4.00 mmHg and diastolic blood pressure by 1.44 mmHg, raised left ventricular ejection fraction by 4.98 percent and improved NYHA heart failure class by 0.40 points, with no significant adverse effects. Those are the outcomes it reported; the cholesterol and triglyceride reductions previously listed here are not among its verified findings. The changes are modest, and many of the pooled trials were run in people with diagnosed heart conditions.